01 2Corden Pharma Bergamo S.p.A.
02 1Fagron Inc
03 1Kalchem International inc
04 2LETCO MEDICAL, LLC
05 1Medisca Inc.
06 1Professional Compounding Centers of America dba PCCA
07 1Spectrum Laboratory Products, Inc.
08 1Unichem Laboratories Limited, India
09 1Xenex Laboratories Inc
01 3METRONIDAZOLE
02 6Metronidazole
03 1Metronidazole Benzoate Micronized
04 1Metronidazole Micronized
01 1Canada
02 1India
03 2Italy
04 1Netherlands
05 5U.S.A
06 1United Kingdom
NDC Package Code : 49964-0002
Start Marketing Date : 2009-11-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49964-0049
Start Marketing Date : 2016-05-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0038
Start Marketing Date : 1998-04-01
End Marketing Date : 2026-01-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 60592-427
Start Marketing Date : 2019-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1685
Start Marketing Date : 2012-04-09
End Marketing Date : 2026-01-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-3180
Start Marketing Date : 2022-10-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0146
Start Marketing Date : 2011-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1449
Start Marketing Date : 2013-06-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4726
Start Marketing Date : 2000-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-007
Start Marketing Date : 2002-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A PYLERA-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PYLERA-1, including repackagers and relabelers. The FDA regulates PYLERA-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PYLERA-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PYLERA-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PYLERA-1 supplier is an individual or a company that provides PYLERA-1 active pharmaceutical ingredient (API) or PYLERA-1 finished formulations upon request. The PYLERA-1 suppliers may include PYLERA-1 API manufacturers, exporters, distributors and traders.
click here to find a list of PYLERA-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PYLERA-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PYLERA-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PYLERA-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PYLERA-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PYLERA-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PYLERA-1 suppliers with NDC on PharmaCompass.
We have 9 companies offering PYLERA-1
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
